Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-11-20 16:10:16
Reporting Period:
Accepted Time:
2019-11-20 16:10:16
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779466 John Goll 700 Us Highway 202/206
Bridgewater NJ 08807
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option Acquisiton 2019-11-18 25,000 $12.58 32,322 No 4 M Direct
Stock Option Disposition 2019-11-18 25,000 $20.04 7,322 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2019-11-18 25,000 $0.00 25,000 $12.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-06-02 No 4 M Direct
  1. This is the weighted average sales price representing 25,000 shares sold at prices ranging from $19.75 to $20.20 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  2. Stock options granted under the Company's 2013 Incentive Plan. These stock options are currently exercisable